D-0277-2024 Class I Ongoing

Recalled by Denver Solutions, LLC DBA Leiters Health — Englewood, CO

FDA drug recall D-0277-2024 was initiated by Denver Solutions, LLC DBA Leiters Health on Dec 28, 2023 and is designated Class I. Reason for recall: Superpotent Drug: semi-automated IV bag filling system can malfunction and provide a double dose of drug product to IV bags. The recall status is ongoing. Affected quantity: 8,976 IV bags.

Recall details

Product Type
Drugs
Report Date
Feb 7, 2024
Initiation Date
Dec 28, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
8,976 IV bags

Product description

FentaNYL citrate PF, 1000 mcg per 100 mL 0.9% Sodium Chloride (10 mcg per mL), Item F3355, for IV use only; Leiters 13796 Compark Blvd Englewood, CO 80112; NDC 71449-072-41.

Reason for recall

Superpotent Drug: semi-automated IV bag filling system can malfunction and provide a double dose of drug product to IV bags.

Distribution pattern

Nationwide within the United States

Code information

Lot #: 2331062, Exp. Date: 02/08/2024; 2331224, Exp. Date 03/18/2024; 2331270, Exp. Date 03/28/2024.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0277-2024
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0277-2024. Report a data issue: hello@regdatalab.com.